CLDX

Celldex Therapeutics Inc. (CLDX)

Stock · NASDAQ · Health Care

$39.12as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$32.33
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances

Celldex Therapeutics Inc. Competitors

Chosen by industry and closest market cap.

  • CLDX
    Celldex Therapeutics Inc.
    $39.12
    ▼ 3.31%
    Market cap $2.96BP/E
  • NEOG
    Neogen Corporation Common Stock
    $11.67
    ▼ 0.60%
    Market cap $2.59BP/E
    $4.9$12.85
  • NNNN
    Anbio Biotechnology Class A Ordinary Shares
    $7.64
    ▼ 1.80%
    Market cap $1.53BP/E 144.72
    $6.61$51.33
  • NTLA
    Intellia Therapeutics Inc. Common Stock
    $12.87
    ▼ 1.83%
    Market cap $1.50BP/E
    $7.95$28.25
  • ACHV
    Achieve Life Sciences Inc. Common Shares
    $8.09
    ▼ 1.16%
    Market cap $648.81MP/E
    $2.62$8.61
  • TKNO
    Alpha Teknova Inc. Common Stock
    $7.13
    ▼ 2.46%
    Market cap $284.15MP/E
    $1.91$7.84
  • ORKA
    Oruka Therapeutics Inc. Common Stock
    $91.07
    ▼ 5.67%
    Market cap $5.72BP/E
    $14.61$115.52

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
71.93M
Total value held
$2.20B
Institutional holders
224
Top holders this quarter
  • Unknown8.56M
  • Unknown5.84M
  • Unknown5.37M
  • Unknown3.75M
  • Unknown3.23M
  • Unknown2.96M
  • Unknown2.80M
  • Unknown2.70M
  • Unknown2.09M
  • Unknown1.79M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.